equityflowunderstand the flow and follow it
EquityFlow › Companies › Draupnir Bio

Draupnir Bio

biotech · Copenhagen, DK

Biotech developing oral small molecule degraders for extracellular proteins.

In the network

Shares the most investors with (number = shared investors):
Antag Therapeutics 2Bactolife 2Chromologics 2MATR Foods 2REDUCED 2

Funding history

DateRoundAmount
Jul 2024Seed
Draupnir Bio raised a €12M seed round from MP Healthcare, EIFO and existing investors to advance its targeted protein degradation pipeline.
$12.6M

Investors

Tap an investor to see what else they have backed.

EIFOGilde Healthcare PartnersMP HealthcareNovo Holdings

Other companies in biotech

Antag TherapeuticsAdcendoFreya BiosciencesTXN SystemsPromise BioConcinnity GeneticsNoema PharmaMabGenesisRadioNano TherapeuticsCitryllAlveron PharmaAQEMIA

Other companies in DK

ReelEveryday^LeafBlinkTrollGetWhySNIPR BiomeJoe & the JuiceHymethVentriJectGrand PMSDropla TechCellugy

Other companies at Seed stage

&Open(Re)vive1-2-Taste100% Livre1000 Satellites100ms10club10pct.10x Science10x.team123Projetei150 Minuten
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.